Management of Vasospastic Disorders with Botulinum Toxin A

@article{Beek2007ManagementOV,
  title={Management of Vasospastic Disorders with Botulinum Toxin A},
  author={Allen L Van Beek and Paul K Lim and A. J. Gear and M. Pritzker},
  journal={Plastic and Reconstructive Surgery},
  year={2007},
  volume={119},
  pages={217-226}
}
  • Allen L Van Beek, Paul K Lim, +1 author M. Pritzker
  • Published 2007
  • Medicine
  • Plastic and Reconstructive Surgery
  • Background: Surgical digital artery sympathectomy is indicated when medical management has failed to control rest pain, impending infarction of digits, or healing of ischemic ulcerations caused by profound vasospasm that is associated with other systemic diseases. After digital artery sympathectomy, recurrence or persistence of vasospasm may compromise hand function and ultimately result in amputation of all or portions of both lower and upper extremities. Methods: The authors present a case… CONTINUE READING
    112 Citations

    Paper Mentions

    Interventional Clinical Trial
    Treating patients with Raynaud's phenomenon who have chronic pain and ulcerations is extremely challenging. Published reports and our previous work support our hypothesis that… Expand
    ConditionsRaynaud's Disease
    InterventionDrug
    Interventional Clinical Trial
    Patients in the intensive care unit (ICU) often require blood pressure support of vasoactive drugs such as amines. Finger necrosis (so called "blue toe syndrome") is a well documented… Expand
    ConditionsCatocholamine Induced Finger Necrosis
    InterventionDrug
    Botox Therapy for Ischemic Digits
    • 83
    Botulinum toxin for Raynaud's phenomenon: an useffull but seldom reminded therapy for severe cases
    • Highly Influenced
    Recent advances for the management of Raynaud phenomenon using botulinum neurotoxin A.
    • 13
    The Role of Botulinum Toxin A in the Treatment of Raynaud Phenomenon
    • 10
    • Highly Influenced
    Long-term results of periarterial sympathectomy.
    • 59
    Iatrogenic Thenar Eminence Atrophy After Botox A Injection for Secondary Raynaud Phenomenon.
    • 3
    Treatment of Raynaud’s phenomenon with botulinum toxin type A
    • 16

    References

    SHOWING 1-10 OF 29 REFERENCES
    Management of finger ulcers in scleroderma.
    • 33
    Digital artery sympathectomy.
    • A. Flatt
    • Medicine
    • The Journal of hand surgery
    • 1980
    • 134
    Botulinum toxin in the treatment of Raynaud's phenomenon: a pilot study
    • 79
    Acute and chronic ischemia of the hand: pathophysiology, treatment, and prognosis.
    • N. Jones
    • Medicine
    • The Journal of hand surgery
    • 1991
    • 56
    Digital sympathectomy for vascular insufficiency.
    • 44